Delivery Order SPE2DB25D3008-SPE2DB25FRDKT
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Prevymis 480 mg tablets in a quantity of seven units, with a contract ceiling value of $4,719.34 and an ultimate completion date of October 7, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Prevymis is an...
- The Defense Logistics Agency awarded a $9,438.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (quantity 7) on September 3, 2025, with an ultimate completion date of September 24, 2025. This non-set-aside competitive award is performed at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Prevymis 480 mg tablets (7-count) with a ceiling value of $9,438.70. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is set for ultimate completion by October 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Prevymis is an antiviral medication...
- The Defense Logistics Agency awarded a $4,719.34 delivery order to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (7-count package) on August 22, 2025, with completion scheduled for September 15, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Prevymis 480 mg tablets (7-count packages) under a firm fixed-price contract with a ceiling value of $4,719.34. The contract type is a delivery order with an ultimate completion date of October 7, 2025, and includes no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform...
- The Defense Logistics Agency awarded a $4,719.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PREVYMIS 480 mg tablets (7-count) on June 18, 2025, with an ultimate completion date of July 11, 2025. This non-set-aside competitive award reflects the pharmaceutical distributor's capability to meet federal medical procurement requirements. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems,...
- The Defense Logistics Agency awarded a $9.4K delivery order to AmerisourceBergen Drug Corp on April 25, 2025, for the supply of Prevymis 480 mg tablets in quantities of seven units. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of May 16, 2025. This delivery order is issued as...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Prevymis 120 mg pellet packets (30-count) under a firm fixed-price contract with a ceiling value of $2,799.86. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 18, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $4.72K firm fixed-price delivery order to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (7-count units) with an ultimate completion date of August 26, 2025. This non-set-aside contract was competitively awarded on August 5, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $9.44K delivery order to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (quantity: 7) under a firm fixed-price contract, with an ultimate completion date of October 9, 2025. This non-set-aside competitive award was issued on September 18, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Prevymis (letermovir) is an antiviral medication used to prevent cytomegalovirus infection in...
- SPE2DB25D3008Indefinite Delivery Contract
- SPE2DB25D3008-SPE2DB25FRDKTDelivery Order
The Defense Logistics Agency awarded a $9,438.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 480 mg tablets of Prevymis (a cytomegalovirus prophylaxis medication), with an ultimate completion date of October 20, 2025. This is a non-set-aside, competitively awarded contract executed on September 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with particular focus on supporting military and veteran healthcare systems. The work will be performed at the contractor's corporate office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical and medical supply support to defense health operations globally. The company supplies a broad range of medical commodities including brand-name and generic medications, vaccines, and specialized healthcare products across multiple therapeutic domains to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 9/26/25 |